Cancer cell‐derived PD‐L1 regulates CD8 + T cell activity, and mechanistically, high levels of PD‐L1 in cancer cells induce CD8 + T cell dysfunction, leading to immune evasion and failure of immune surveillance (Fang et al., 2021). This evidence concerns the gene CD8A and cancer.